Plasminogen - safe for treatment of chronic tympanic membrane perforation: a phase 1 randomized, placebo-controlled study

This pilot study suggests that plasminogen injections close to the tympanic membrane as treatment for chronic tympanic membrane injections are safe and feasible, encouraging further dose-escalating studies.

Authors

Institutions

Publication Details

Journal
Acta Oto-Laryngologica
Published
2024-08-12
DOI
https://doi.org/10.1080/00016489.2024.2396488
Citations
2
Primary Topic
Ear Surgery and Otitis Media
Type
article
Field-Weighted Citation Impact
1.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Plasminogen - safe for treatment of chronic tympanic membrane perforation: a phase 1 randomized, placebo-controlled study

Bo Tideholm, Cecilia Engmér Berglin, Elnaz Sepehri, Sten Hellström
2 citations
Acta Oto-Laryngologica
Ear Surgery and Otitis Media
1.16
article

Plasminogen - safe for treatment of chronic tympanic membrane perforation: a phase 1 randomized, placebo-controlled study

Bo Tideholm, Cecilia Engmér Berglin, Elnaz Sepehri, Sten Hellström
article en
2 citations

Abstract

This pilot study suggests that plasminogen injections close to the tympanic membrane as treatment for chronic tympanic membrane injections are safe and feasible, encouraging further dose-escalating studies.

Acta Oto-LaryngologicaVol. 144(7-8)
Karolinska University Hospital (SE), Karolinska Institutet (SE)
Good health and well-being
Openalex Percentile: Top 21%
Ear Surgery and Otitis Media
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Plasminogen - safe for treatment of chronic tympanic membrane perforation: a phase 1 randomized, placebo-controlled study — Bo Tideholm, Cecilia Engmér Berglin, et al. · Acta Oto-Laryngologica (2024) | TGRS Research Map | TGRS